Sumitomo Dainippon Pharma Co., Ltd.[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2018	1
2022	2
2023	1
2024	0

Page 1

Alvocidib inhibits IRF4 expression via super-enhancer suppression and adult T-cell leukemia/lymphoma cell growth.

Sakamoto H, Ando K, Imaizumi Y, Mishima H, Kinoshita A, Kobayashi Y, Kitanosono H, Kato T, Sawayama Y, Sato S, Hata T, Nakashima M, Yoshiura KI, Miyazaki Y. Sakamoto H, et al. Cancer Sci. 2022 Dec;113(12):4092-4103. doi: 10.1111/cas.15550. Epub 2022 Oct 3. Cancer Sci. 2022. PMID: 36047964 Free PMC article.

Circulating selenoprotein P levels predict glucose-lowering and insulinotropic effects of metformin, but not alogliptin: A post-hoc analysis.

Takeshita Y, Tanaka T, Takayama H, Kita Y, Goto H, Nakano Y, Saito Y, Takamura T. Takeshita Y, et al. J Diabetes Investig. 2023 Feb;14(2):230-235. doi: 10.1111/jdi.13949. Epub 2022 Dec 7. J Diabetes Investig. 2023. PMID: 36479595 Free PMC article. Clinical Trial.

Blockade of dopamine D₁ receptors, but not D₂ receptors, decreases motivation in a novel effort-discounting paradigm in common marmosets.

Enomoto T, Konoike N, Takemoto A, Nakamura K, Ikeda K. Enomoto T, et al. Behav Neurosci. 2018 Dec;132(6):526-535. doi: 10.1037/bne0000273. Epub 2018 Oct 8. Behav Neurosci. 2018. PMID: 30299146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year